Mira Grant. Orbit, $20 (512p) ISBN 978-0-316-21895-5
In the year 2021, a car crash leaves 20-year-old Sally Mitchell amnesiac. She owes her life to the apparently benign implant of a genetically engineered tapeworm developed by SymboGen. Six years after the crash, as Sally seeks to recover her identity, outbreaks of sinister “sleepwalking” incidents—ignored by the media—fuel Grant’s mordant satire of the corporate public relations world. SymboGen’s widely accepted patented Intestinal Bodyguard tapeworm suppresses illnesses, but Sally’s boyfriend, parasitologist Nathan Kim, wonders what the cost is. A running series of comments by Symbogen cofounder Dr. Steven Banks and his renegade former colleague Dr. Shanti Cale provide a parallel to Sally’s desperate quest for information, as SymboGen’s good intentions become increasingly suspect. Grant extends the zombie theme of her Newsflesh trilogy to incorporate thoughtful reflections on biomedical issues that are both ominously challenging and eerily plausible. Sally is a complex, compassionate character, well suited to this exploration of trust, uncertainty, and the price of progress. Agent: Diana Fox, Fox Literary. (Nov.)
Reviewed on: 08/05/2013
Release date: 10/29/2013
Show other formats
Open Ebook - 1 pages - 978-1-306-76343-1
Hardcover - 512 pages - 978-1-4055-1868-0
Hardcover - 504 pages - 978-0-356-50192-5
Open Ebook - 608 pages - 978-0-316-21893-1
MP3 CD - 978-1-4789-2603-0
Hardcover - 252 pages - 978-0-316-40231-6
Paperback - 512 pages - 978-0-316-21892-4
Stay ahead with
Tip Sheet!
Free newsletter: the hottest new books, features and more
Only $18.95/month for Digital Access
or $20.95 for Print+Digital Access!
Only $18.95/month for Digital Access
or $20.95 for Print+Digital Access!
Email Address


Log In Lost Password

PW has integrated its print and digital subscriptions, offering exciting new benefits to subscribers, who are now entitled to both the print edition and the digital editions of PW (online or via our app). For instructions on how to set up your accout for digital access, click here. For more information, click here.

The part of the site you are trying to access is now available to subscribers only. Subscribers: to set up your digital subscription with the new system (if you have not done so already), click here. To subscribe, click here.

Email with questions.

Not Registered? Click here.